Traduction de «opinion of scientific panel » (Néerlandais → Français) :

Opinion of Scientific Panel related to the Tolerable Upper Intake Level of Fluoride (EFSA-Q-2003-018).
Révision de l’avis fluor 8520 : Fluor(-ure) en prévention de la carie dentaire.

Opinion of the Scientific Panel on Dietetic Products, Nutrition and allergies on a request from the Commission related to the Tolerable Upper Intake Level of Fluoride (Request N° EFSA-Q-2003-018).
Recommandations nutritionnelles pour la Belgique (Révision 2009).

Een tijd later heeft de Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Foods van de EFSA (EFSA, 2008a) deze ADI van 0,5 mg/kg/dag gevalideerd voor alle bronnen van lycopeen, ook dat uit tomaat, op basis van een NOAEL-waarde van 50 mg/kg/dag (No-Observed- Adverse-Effect Level) en bij toepassing van een veiligheidsfactor van 100.
Un peu plus tard, le Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Foods de l’EFSA (EFSA, 2008a) a validé cette DJA de 0,5 mg/kg/jour pour toutes les sources de lycopène, en ce compris celui extrait de la tomate, en se basant sur un NOAEL de 50 mg/kg/jour (No-Observed-Adverse-Effect Level) et en utilisant un facteur de sécurité de 100.

EFSA - European Food Safety Authority. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.

Provision has been made for the organised exchange of information with the national scientific commissions which give final opinions (e.g. evaluation commissions for medicines) and with the representatives on the international scientific or regulatory committees (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, PDCO).
Provision has been made for the organised exchange of information with the national scientific commissions which give final opinions (e.g. evaluation commissions for medicines) and with the representatives on the international scientific or regulatory committees (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, PDCO).

In this scientific advisory report, the Superior Health Council provides an expert opinion on screening for cardiac abnormalities that predispose to
In this scientific advisory report, the Superior Health Council provides an expert opinion on screening for cardiac abnormalities that predispose to sudden cardiac death among the adolescents and young adults

On a European level, the Scientific Committee on Food (SCF) issued a first opinion on caffeine, taurine and D-glucuronolactone as ingredients of energy drinks in 1999 (SCF, 1999).
Au niveau européen, le Scientific Committee on Food (SCF) a rendu en 1999 un premier avis concernant la caféine, la taurine et le D-glucuronolactone comme constituants des boissons énergisantes (SCF, 1999).

Opinion on the scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies (PDF, 22 p., 487 KB).
Opinion on the scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies (format PDF - 22 pages - 487 KB).

Preliminary opinion on the oral exposure of humans to the BSE agent: infective dose and species barrier, adopted by the Scientific Steering Committee at its meeting of 2-3 March.
Preliminary opinion on the oral exposure of humans to the BSE agent: infective dose and species barrier, adopted by the Scientific Steering Committee at its meeting of 2-3 March 2000.

In 2007, 60 formal scientific opinions were issued, a number of which were further coordinated by the Belgian delegation in the SAWP.
In 2007, 60 formal scientific opinions were issued, a number of which were further coordinated by the Belgian delegation in the SAWP.